1. Home
  2. PSTV vs APDN Comparison

PSTV vs APDN Comparison

Compare PSTV & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • APDN
  • Stock Information
  • Founded
  • PSTV 1996
  • APDN 1983
  • Country
  • PSTV United States
  • APDN United States
  • Employees
  • PSTV N/A
  • APDN N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • APDN Other Consumer Services
  • Sector
  • PSTV Health Care
  • APDN Consumer Discretionary
  • Exchange
  • PSTV Nasdaq
  • APDN Nasdaq
  • Market Cap
  • PSTV 2.1M
  • APDN 2.0M
  • IPO Year
  • PSTV N/A
  • APDN N/A
  • Fundamental
  • Price
  • PSTV $0.93
  • APDN $1.66
  • Analyst Decision
  • PSTV Strong Buy
  • APDN Strong Buy
  • Analyst Count
  • PSTV 3
  • APDN 1
  • Target Price
  • PSTV $11.17
  • APDN $75.00
  • AVG Volume (30 Days)
  • PSTV 47.0M
  • APDN 2.6M
  • Earning Date
  • PSTV 03-27-2025
  • APDN 05-09-2025
  • Dividend Yield
  • PSTV N/A
  • APDN N/A
  • EPS Growth
  • PSTV N/A
  • APDN N/A
  • EPS
  • PSTV N/A
  • APDN N/A
  • Revenue
  • PSTV $5,824,000.00
  • APDN $3,736,873.00
  • Revenue This Year
  • PSTV N/A
  • APDN $57.08
  • Revenue Next Year
  • PSTV N/A
  • APDN $40.00
  • P/E Ratio
  • PSTV N/A
  • APDN N/A
  • Revenue Growth
  • PSTV 18.54
  • APDN N/A
  • 52 Week Low
  • PSTV $0.24
  • APDN $1.45
  • 52 Week High
  • PSTV $2.67
  • APDN $450.00
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 46.88
  • APDN 22.14
  • Support Level
  • PSTV $0.94
  • APDN $1.45
  • Resistance Level
  • PSTV $1.77
  • APDN $2.39
  • Average True Range (ATR)
  • PSTV 0.31
  • APDN 0.34
  • MACD
  • PSTV -0.00
  • APDN 0.07
  • Stochastic Oscillator
  • PSTV 27.68
  • APDN 14.39

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About APDN Applied DNA Sciences Inc.

Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Share on Social Networks: